| Wood Lake Health And Rehabilitation Center | |
| 6414 13th Rd S, Green Acres, Florida 33415 | |
| (561) 478-9900 | |
| Name | Wood Lake Health And Rehabilitation Center |
|---|---|
| Location | 6414 13th Rd S, Green Acres, Florida |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 75.83% |
| Medicare ID (CCN) | 105611 |
| Legal Business Name | 6414 13th Road South Operations Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1255387601 |
| Organization Name | WOOD LAKE HEALTH CARE ASSOCIATES LLC |
| Doing Business As | WOOD LAKE HEALTH AND REHABILITATION CENTER |
| Address | 6414 13th Rd S, West Palm Beach, FL 33415 |
| Phone Number | 561-478-9900 |
News Archive
To reduce the number of traumatic brain injuries in children, a team of health care professionals at the Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health is urging emergency room physicians to help ensure that youngsters are thoroughly educated on the proper use of bike helmets, especially in urban environments where most severe head injuries occur.
With no way to reliably tell whether an athlete has a concussion, many may be playing with an undiagnosed injury. Likewise, 2 million people die every year because we don't have an early warning when brain cells are dying-and another 4 million experience cognitive disabilities.
A novel molecule designed by scientists at the University of Massachusetts Medical School and the University of Virginia inhibits progression of a hard-to-treat form of recurring acute myeloid leukemia (AML) in patient tissue.
Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
› Verified 4 days ago
| NPI Number | 1750650610 |
| Organization Name | 6414 13TH ROAD SOUTH OPERATIONS LLC |
| Doing Business As | WOOD LAKE HEALTH AND REHABILITATION CENTER |
| Address | 6414 13th Road S, W. Palm Beach, FL 33415 |
| Phone Number | 561-478-9900 |
News Archive
To reduce the number of traumatic brain injuries in children, a team of health care professionals at the Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health is urging emergency room physicians to help ensure that youngsters are thoroughly educated on the proper use of bike helmets, especially in urban environments where most severe head injuries occur.
With no way to reliably tell whether an athlete has a concussion, many may be playing with an undiagnosed injury. Likewise, 2 million people die every year because we don't have an early warning when brain cells are dying-and another 4 million experience cognitive disabilities.
A novel molecule designed by scientists at the University of Massachusetts Medical School and the University of Virginia inhibits progression of a hard-to-treat form of recurring acute myeloid leukemia (AML) in patient tissue.
Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
› Verified 4 days ago
| NPI Number | 1780017657 |
| Organization Name | GENESIS REHAB SERVICES |
| Address | 6414 13th Rd. South, Woodlake, West Palm Beach, FL 33415 |
| Phone Number | 561-478-9900 |
News Archive
To reduce the number of traumatic brain injuries in children, a team of health care professionals at the Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health is urging emergency room physicians to help ensure that youngsters are thoroughly educated on the proper use of bike helmets, especially in urban environments where most severe head injuries occur.
With no way to reliably tell whether an athlete has a concussion, many may be playing with an undiagnosed injury. Likewise, 2 million people die every year because we don't have an early warning when brain cells are dying-and another 4 million experience cognitive disabilities.
A novel molecule designed by scientists at the University of Massachusetts Medical School and the University of Virginia inhibits progression of a hard-to-treat form of recurring acute myeloid leukemia (AML) in patient tissue.
Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
› Verified 4 days ago
| NPI Number | 1902585177 |
| Organization Name | 13TH ROAD OPCO LLC |
| Doing Business As | ASPIRE AT GREENACRES |
| Address | 6414 13th Rd S, Greenacres, FL 33415 |
| Phone Number | 561-478-9900 |
News Archive
To reduce the number of traumatic brain injuries in children, a team of health care professionals at the Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health is urging emergency room physicians to help ensure that youngsters are thoroughly educated on the proper use of bike helmets, especially in urban environments where most severe head injuries occur.
With no way to reliably tell whether an athlete has a concussion, many may be playing with an undiagnosed injury. Likewise, 2 million people die every year because we don't have an early warning when brain cells are dying-and another 4 million experience cognitive disabilities.
A novel molecule designed by scientists at the University of Massachusetts Medical School and the University of Virginia inhibits progression of a hard-to-treat form of recurring acute myeloid leukemia (AML) in patient tissue.
Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
› Verified 4 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
To reduce the number of traumatic brain injuries in children, a team of health care professionals at the Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health is urging emergency room physicians to help ensure that youngsters are thoroughly educated on the proper use of bike helmets, especially in urban environments where most severe head injuries occur.
With no way to reliably tell whether an athlete has a concussion, many may be playing with an undiagnosed injury. Likewise, 2 million people die every year because we don't have an early warning when brain cells are dying-and another 4 million experience cognitive disabilities.
A novel molecule designed by scientists at the University of Massachusetts Medical School and the University of Virginia inhibits progression of a hard-to-treat form of recurring acute myeloid leukemia (AML) in patient tissue.
Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
› Verified 4 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 0 |
| Total Amount of Fines in Dollars | $0 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 0 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 10.74 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 9.39 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 64.86 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 1.24 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 1.2 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 0 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 2 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.43 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 5.84 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 91.81 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0.69 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 25.72 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.25 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 11.55 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.48 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 76.45 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 90.15 | 82.93 |
News Archive
To reduce the number of traumatic brain injuries in children, a team of health care professionals at the Johns Hopkins University School of Medicine and the Johns Hopkins Bloomberg School of Public Health is urging emergency room physicians to help ensure that youngsters are thoroughly educated on the proper use of bike helmets, especially in urban environments where most severe head injuries occur.
With no way to reliably tell whether an athlete has a concussion, many may be playing with an undiagnosed injury. Likewise, 2 million people die every year because we don't have an early warning when brain cells are dying-and another 4 million experience cognitive disabilities.
A novel molecule designed by scientists at the University of Massachusetts Medical School and the University of Virginia inhibits progression of a hard-to-treat form of recurring acute myeloid leukemia (AML) in patient tissue.
Biologics, a limited distribution network partner for IMBRUVICA™ (ibrutinib), is pleased to announce the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™ (ibrutinib) capsules as a single, oral agent for the treatment of patients with chronic lymphocytic leukemia (CLL) who have received at least one prior therapy.
› Verified 4 days ago
Wood Lake Health And Rehabilitation Center Location: 6414 13th Rd S, Green Acres, Florida 33415 Phone: (561) 478-9900 |